The ADAPT study will evaluate the safety and effectiveness of the company's Calibreye™ Titratable Glaucoma Therapy™ (TGT) Surgical System
CAMPBELL, Calif., Aug. 12, 2025 /PRNewswire/...
Newly formed MSO to support orthopedic practices and ASCs with strategic growth, back-end operations and clinical autonomy
LATHAM, N.Y., Aug. 12, 2025 /PRNewswire/ -- Evolve Orthopedic...
KOLKATA, India, Aug. 12, 2025 /PRNewswire/ -- Manipal Hospitals - EM Bypass (erstwhile Medica Superspecialty Hospital), Kolkata is thrilled to announce the completion of 50...
– Webcasted Q2-2025 conference call scheduled for August 26th at 5:00 PM EDT –
TORONTO and DALLAS, Aug. 11, 2025 /PRNewswire/ - Perimeter Medical Imaging AI,...
– Webcasted Q2-2025 conference call scheduled for August 26th at 5:00 PM EDT –
TORONTO and DALLAS, Aug. 11, 2025 /CNW/ - Perimeter Medical Imaging AI,...
Dr. David Salehani, a top Los Angeles oral and maxillofacial surgeon, is revolutionizing chin and jaw surgeries using Virtual Surgical Planning (VSP), a 3D planning...
STAFFORD, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today provided the following update on CEO interviews and corporate events.
- The company strengthens brand experience for local medical professionals through academic events and hands-on workshops
- It will solidify the market position of premium...
PALM BEACH GARDENS, Fla., Aug. 9, 2025 /PRNewswire/ -- For patients considering plastic surgery with underlying medical conditions, Dr. Thomas A. Pane, MD, offers...